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http://dxObjective: Prolonged intubation has been implicated in the poor outcomes after adult cardiac surgery. Accel-
erated postoperative extubation has been a quality focus, but operating room (OR) extubation after cardiopul-
monary bypass is rare. We examined the outcomes and direct costs of protocolized OR extubation versus
early postoperative intensive care unit (ICU) extubation after nonemergency open cardiac surgery.
Methods: From January 2012 to June 2013, 652 consecutive patients who had undergone various cardiac op-
erations, including redo and multivalve operations, were extubated within 12 hours, 165 in the OR. The OR ex-
tubation patients were propensity matched frommultivariable logistic regression to derive 106 matched pairs for
OR extubation versus extubation<12 hours (group 1) and 98 independently matched pairs for OR extubation
versus extubation<6 hours (group 2).
Results: OR versus ICU extubation conveyed significant reductions in ICU hours (26.3, interquartile range
[IQR], 22.0-31.0; vs 29.0, IQR, 25.0-51.0; P ¼ .001, for group 1; 27.0, IQR, 22.0-32.0; vs 29.0, IQR, 25.0-
54.0; P ¼ .0002, for group 2) and postoperative length of stay (5 days, IQR, 4-6; vs 6 days, IQR, 5-7;
P ¼ .0008, for group 1; 5 days, IQR, 4-6; vs 6 days, IQR, 4-7; P ¼ .0002, for group 2) but did not affect the
reintubation rate (1.9% [2 of 106] vs 0.0% [0 of 106], P ¼ .5, group 1; 3.1% [3 of 98] vs 2.0% [2 of 98],
P ¼ 1.0, group 2). OR versus ICU extubation conferred a>20% cost reduction from surgery completion to
discharge ($3055, IQR, $2576-$3964; vs $3977, IQR, $3028-$4947; P ¼ .0007, group 1; $3025, IQR,
$2598-$3965, vs $3877, IQR, $2998-$5458; P ¼ .007, group 2).
Conclusions: After cardiac surgery, OR extubation is safe and might provide improvement in length of stay and
cost compared with early postoperative ICU extubation. (J Thorac Cardiovasc Surg 2014;148:3101-9)P
MSupplemental material is available online.
Prolonged intubation after adult cardiac surgery has been
implicated in protracted intensive care unit (ICU) times
and postoperative length of stay (LOS).1,2 Defined as
mechanical ventilation> 24 hours, the hospital rates of
postoperative prolonged intubation are currently tracked
as a National Quality Forum performance indicator owing
to the known associations with greater rates of nosocomial
pneumonia, 30-day operative mortality, and poore Heart and Vascular Institute, University of Pittsburgh Medical Center,
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The Journal of Thoracic and Caroutcomes.3-5 Early extubation after cardiac surgery has
been linked to safe improvements in LOS, resource usage,
and mortality.5-7 The timelines of outcome-enhancing
‘‘fast-track’’ cardiac anesthesiamanagement remain incom-
pletely defined, ranging from<12 hours to<6 hours.8-10
Although expedient extubation after cardiac operations
remains controversial,11-13 protocolized pathways to
decrease ventilator time have shown incremental time-
related improvement in outcomes without increasing com-
plications such as reintubation.14-16 Experience with safe
operating room (OR) extubation after adult cardiac
surgery remains rare and currently confined to highly
selected patients and operation types.16-18 Therefore, our
objective was to assess the effect of OR extubation in a
propensity-matched comparison to early postoperative
ICU extubation on the outcomes and cost after all nonemer-
gency open cardiac operations.
METHODS
Patient Population
From January 1, 2012, to June 30, 2013, 888 patients underwent adult
cardiac surgery at the Presbyterian University Hospital of the University
of Pittsburgh Medical Center. Our study cohort of 652 consecutive patients
receiving all forms of open cardiac operations who had been extubated
within 12 hours was formed after excluding 197 operations defined asdiovascular Surgery c Volume 148, Number 6 3101
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
ICU ¼ intensive care unit
IQR ¼ interquartile range
LOS ¼ length of stay
OR ¼ operating room
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Memergent, those performed for acute bacterial endocarditis, transcatheter
aortic valve replacement, transplantation, or requiring deep hypothermic
circulatory arrest, shock, or ventricular assist device implantation, and 39
patients requiring ventilation> 12 hours. The inclusion and exclusion
patient flow diagram is illustrated in Figure 1. OR extubation was achieved
in 165 patients. Of the 487 patients extubated in the ICU within<12 hours,
356 were extubated within<6 hours. Preoperative baseline demographic
and clinical comorbid risk variables and operative procedural variables
were recorded and analyzed with the approval of the institutional review
board of the University of Pittsburgh Medical Center.FIGURE 1. Flow diagram displaying the sequence of patient inclusion,
classification of extubation in the operating room, and outside the operating
room, and identification of the matched pair groups. ICU, Intensive care
unit; TAVR, transcatheter aortic valve replacement.Anesthesia and Extubation Protocol
All patients in the present study underwent a similar protocolized
approach to cardiac anesthesia induction, maintenance, and emergence.
After anesthetic informed consent was obtained, a limited dose of 1 to 2
mg midazolam premedication was administered in the preoperative hold-
ing area or on arrival to the operating room. Although the most common
surgical approach was sternotomy, in selected thoracotomy patients, we
used intrathecal morphine for postoperative analgesia that was adminis-
tered before anesthetic induction. For these cases, the patients were placed
in sitting position, and 0.2 to 0.5 mg of intrathecal morphine was adminis-
tered after confirmation of cerebrospinal fluid aspiration through a 25-
guage spinal needle. The patients undergoing sternotomy or those with
altered coagulation profiles, severe back pain, previous back surgery, or
refusal of regional anesthesia did not receive an intrathecal injection. After
application of the monitors, all patients were placed in the supine position,
and an invasive arterial line was inserted before induction. An initial
limited dose of a short-acting opioid,<100 mg fentanyl, was administered
during induction. Additional dosing of the opioid analgesic was individu-
alized at the clinical discretion of the cardiac anesthesiologist. Only fenta-
nyl or fentanyl plus hydromorphone was used for analgesia, with the total
dose of fentanyl limited to 250 to 500 mg and hydromorphone to 1 to 2 mg.
Hydromorphone was generally not administered if intrathecal morphine
was used. After induction of general anesthesia with propofol or etomidate,
a volatile agent, usually isoflurane, was used for maintenance of anesthesia
before the institution of cardiopulmonary bypass. No additional benzodiaz-
epines were given, and the depth of anesthesia was maintained only with
inhalational agents. The anesthetic depth was monitored to a bispectral in-
dex target of 40 to 60 throughout the operation. After separation from car-
diopulmonary bypass, a short-acting volatile agent such as desflurane or
sevoflurane was substituted for isoflurane. Throughout the procedure, the
neuromuscular blockade was monitored very closely, with the anticipation
of blockade reversal at procedure completion. Intravenous acetaminophen
was often administered to further augment the analgesia. After completion
of each procedure, the neuromuscular blockade was reversed, and the pa-
tients were extubated once the typical criteria had been fulfilled. The extu-
bation criteria included normothermia, stable hemodynamics, the absence
of mediastinal bleeding, adequate muscle strength and respiratory effort
with a tidal volume of>5 mL/kg, and a fully awake patient capable of
following commands. The patients who did not fulfill the criteria in the
OR were given temporary propofol or dexmedetomidine sedation only
for ICU transport. On arrival at the ICU and the initial ICU assessment,
the sedation was discontinued and weaning from mechanical ventilation3102 The Journal of Thoracic and Cardiovascular Surwas initiated according to a preset nursing and respiratory therapist proto-
col. Once the criteria had been fulfilled, the patients were extubated, and
the time was recorded in the electronic medical record. Postoperative anal-
gesia after extubation was provided with acetaminophen, limited intrave-
nous morphine to a maximum of 10 mg/h, or oral oxycodone, as
appropriate, to a visual analog pain scale score of<4.
Propensity Score and Statistical Analyses
The baseline demographic, clinical, and procedural characteristics were
compared between the 165 patients extubated in the OR and the 487 pa-
tients extubated in the ICU within<12 hours. All preoperative and opera-
tive variables from our institutional Society of Thoracic Surgeons, version
2.73, adult cardiac surgery database were used without exclusion to create
propensity scores for OR extubation from multivariable logistic regression
to create 2 matched groups: OR extubation versus ICU extubation within
<12 hours (group 1) and OR extubation versus ICU extubation within
<6 hours (group 2). Within each group, the propensity score represented
the probability that a patient would undergo OR extubation instead of
ICU extubation. Two independent multivariable logistic regression models
were created, and the corresponding propensity scores for each patient
were calculated. Stepwise regression methods using an a of 0.20 threshold
were used to select and retain the variables in the propensity logistic regres-
sion model. Hosmer-Lemeshow statistics were used to evaluate the good-
ness of fit of the propensity model. The baseline characteristics for thegery c December 2014
Badhwar et al Perioperative Managementmatched patient sets were compared to ensure adequate balance. The
model demonstrated reasonable goodness of fit (Hosmer-Lemeshow statis-
tic, 8.48, 8 df, P ¼ .39), and the propensity scores among the 652 patients
representing the predicted probability of extubation ranged from 0.002 to
0.96. From the calculated propensity scores, patients undergoing OR extu-
bation were randomly sequenced and matched 1:1 without replacement
with the ICU extubation patients using a caliper distance of 0.10 to derive
106 matched pairs in group 1 (n ¼ 212) and 98 independently matched
pairs in group 2 (n ¼ 196).
In addition to the clinical outcomes between the groups and extubation
status, the primary endpoints were the assessment of ICU hours, postoper-
ative LOS in days, reintubation rate, and the rate of direct home discharge
without skilled nursing. Direct cost accounting for each patient was exam-
ined by a review of the institutional financial records from surgery comple-
tion to discharge.
The data are presented as the mean standard deviation or median and
interquartile range (IQR) for continuous variables and as proportions for
categorical variables. Wilcoxon rank-sum tests were used to compare
continuous variables and the chi-square test or Fischer’s exact test was
used, when appropriate, for dichotomous variables. The analyses were per-
formed using Statistical Analysis Systems, version 9.2, and R (SAS Insti-
tute Inc, Cary, NC).P
MRESULTS
Patient Characteristics
Before propensity matching of the full cohort, the OR ex-
tubation patients were more likely to have undergone elec-
tive surgery, were slightly younger, leaner, and more
commonly male, and had fewer symptoms of heart failure
or angina than the patients extubated within<12 hours in
the ICU. Similarly, only 40% (66 of 165) of the OR extuba-
tion patients had undergone a full sternotomy compared
with 90.6% (441 of 487) of those extubated in the ICU
(P<.0001). However, although the unmatched OR extuba-
tion patients were more likely to have undergone minimally
invasive right thoracotomy (38.8% [64 of 165]), 63.6%
(105 of 165) underwent open valve operations compared
with only 39.2% (191 of 487) of the ICU extubation popu-
lation. After multivariable propensity score regression
modeling, the factors independently associated with OR
extubation were active smoking, a lower body mass index,
unstable angina at presentation, and full sternotomy
(Appendix Table E1). After even matching between groups
1 and 2, the previously highlighted differences in operation
type, incision type, and elective status were eliminated in
the matched data sets used for the remainder of the analyses
(Table 1).Outcome for Propensity Score-Matched Sets
The matched analyses of the study endpoints demon-
strated that extubation in the OR resulted in similar clinical
outcomes and safety parameters compared with early extu-
bation in the ICU but with lower healthcare usage and cost
(Table 2). No difference was found in the total operative
time between OR and ICU extubation (median, 374 minutes
[IQR, 316-441] vs median, 378 minutes [IQR, 331-428];
P ¼ .32 for group 1; median, 379 minutes [IQR, 316-439]The Journal of Thoracic and Carvs median, 384 minutes [IQR, 339-432]; P ¼ .21 for group
2). A small numeric difference was found in the minutes
from ‘‘drapes off’’ to ‘‘wheels out’’ between patients extu-
bated in the OR and patients extubated in the ICU (median,
22 minutes [IQR, 19-31] vs median, 20 [IQR, 15-25];
P ¼ .0035, group 1; median, 23 minutes [IQR, 19-31] vs
median, 20 minutes [IQR, 15-25]; P¼ .0024, group 2). Ex-
tubation in the OR versus early postoperatively in the ICU
did not significantly affect the composite frequency of any
postoperative complication (27.4% [29 of 106] vs 38.7%
[41 of 106], P ¼ .09, group 1; 27.6% [27 of 98] vs
40.8% [40 of 98], P ¼ .06, group 2; Figure 2, A) or the re-
intubation rate (1.9% [2 of 106] vs 0.0% [0 of 106], P¼ .5,
group 1; 3.1% [3 of 98] vs 2.0% [2 of 98], P ¼ 1.0, group
2). Similarly, the extubation location had no bearing on the
incidence of major morbidity or mortality (Table 2). How-
ever, in the matched samples, the patients extubated in the
OR had significant reductions in postoperative ICU hours
compared with those extubated early in the ICU (median,
26.3 [IQR, 22.0-31.0] vs median, 29.0 [IQR, 25.0-51.0],
P ¼ .001, group 1; median, 27.0 [IQR, 22.0-32.0] vs me-
dian, 29.0 [IQR, 25.0-54.0], P ¼ .0002, group 2), with
similar reductions seen in surgery completion to discharge
LOS (median, 5 days [IQR, 4-6] vs median, 6 days [IQR,
5-7], P ¼ .0008, group 1; median, 5 days [IQR, 4-6] vs me-
dian, 6 days [IQR, 4-7], P¼ .0002, group 2; Figure 2, B). In
a subset analysis excluding all minimally invasive opera-
tions, the findings were identical (Table 3). Moreover, extu-
bation in the OR led to significantly greater rates of direct to
home dischargewithout the need for skilled nursing interval
rehabilitation (88.7% [94 of 106] vs 72.6% [77 of 106],
P ¼ .0009, group 1; 88.8% [87 of 98] vs 73.5% [72 of
98], P ¼ .01, group 2; Figure 2, A). An overall>20%
cost reduction from surgery completion to discharge was
associated with OR extubation compared with early ICU
extubation (median, $3055 [IQR, $2576-$3964] vs median,
$3977 [IQR, $3028-$4947], P ¼ .0007, group 1; median,
$3025 [IQR, $2598-$3965] vs median, $3877 [IQR,
$2998-$5458], P ¼ .007, group 2).
DISCUSSION
We investigated protocolized OR extubation after all
nonemergency open cardiac operations, including redo op-
erations and multivalve procedures, performed by way of
sternotomy and nonsternotomy approaches, and compared
the outcomes and cost to propensity-matched cases of early
ICU extubation. The key finding of the present study was
that OR extubation can be safely performed without
augmented risk of reintubation and confers significant ben-
efits over early postoperative or ‘‘fast-track’’ extubation.
Case Selection and Outcomes
Avoidance of prolonged mechanical ventilation after
adult cardiac surgery is a known international quality metricdiovascular Surgery c Volume 148, Number 6 3103
TABLE 1. Baseline and operative characteristics of total population and propensity-matched groups by extubation status
Characteristic
Full patient population (n ¼ 652) Group 1 (n ¼ 212) Group 2 (n ¼ 196)
Extubated
in OR
(n ¼ 165)
Extubated
12 h
(n ¼ 487) P value
Extubated
in OR
(n ¼ 106)
Extubated
12 h
(n ¼ 106) P value
Extubated
in OR
(n ¼ 98)
Extubated
<6 h
(n ¼ 98) P value
Age (y) 57.8  12.8 65.2  12.0 <.0001 60.6  12 59.8  14.1 .6564 60.6  12.3 61.5  14.4 .6400
Female sex 31.5 (52) 36.6 (178) .2421 29.2 (31) 31.1 (33) .7648 30.6 (30) 31.6 (31) .8774
BMI (kg/m2) 27.3  5.1 29.3  6.3 <.0001 28.2  5.5 27.6  5.3 .3849 27.8  5.5 27.9  5.3 .9909
CHF 57.6 (95) 43.3 (211) .0015 46.2 (49) 43.4 (46) .6786 42.9 (42) 48.0 (47) .4732
Class I 7.4 (7) 0.5 (1) <.0001 0 0 .8937 0 0 .2971
Class II 35.8 (34) 22.3 (47) 22.4 (11) 26.1 (12) 19.0 (8) 31.9 (15)
Class III 48.4 (46) 59.2 (125) 63.3 (31) 58.7 (27) 64.3 (27) 48.9 (23)
Class IV 8.4 (8) 18.0 (38) 14.3 (7) 15.2 (7) 16.7 (7) 19.1 (9)
Diabetes 23.0 (38) 38.4 (187) .0003 30.2 (32) 30.2 (32) 1.0000 31.6 (31) 28.6 (28) .6404
Last HbA1c level 5.7 (5.4-6.0) 5.9 (5.5-6.5) <.0001 5.8 (5.4-6.2) 5.7 (5.5-6.3) .6376 5.8 (5.5-6.2) 5.7 (5.5-6.2) .9688
Dialysis 1.8 (3) 2.5 (12) .6325 2.8 (3) 0.9 (1) .3127 3.1 (3) 1.0 (1) .3123
Hypertension 72.1 (119) 89.7 (437) <.0001 82.1 (87) 84.0 (89) .7145 80.6 (79) 86.7 (85) .2462
CVD 12.1 (20) 19.5 (95) .0315 12.3 (13) 12.3 (13) 1.0000 14.3 (14) 21.4 (21) .1917
CVA 3.0 (5) 7.8 (38) .0340 3.8 (4) 4.7 (5) .7334 4.1 (4) 8.2 (8) .2334
Chronic lung disease .0007 .0528 .3068
Mild 10.3 (17) 12.9 (63) 14.2 (15) 6.6 (7) 14.3 (14) 10.2 (10)
Moderate 5.5 (9) 9.9 (48) 5.7 (6) 7.5 (8) 7.1 (7) 9.2 (9)
Severe 0.6 (1) 7.6 (37) 0.9 (1) 6.6 (7) 1.0 (1) 5.1 (5)
PVD 10.9 (18) 24.6 (120) .0002 14.2 (15) 14.2 (15) 1.0000 16.3 (16) 16.3 (16) 1.0000
Immunosuppressive therapy 4.8 (8) 5.3 (26) .8066 5.7 (6) 5.7 (6) 1.0000 7.1 (7) 6.1 (6) .7741
Risk factors
Current/recent smoker 20.0 (33) 18.7 (91) .7101 22.6 (24) 25.5 (27) .6298 26.5 (26) 24.5 (24) .7431
Home oxygen 0.6 (1) 3.9 (19) .0339 0.9 (1) 2.8 (3) .3127 1.0 (1) 3.1 (3) .3123
Inhaled bronchodilator 9.1 (15) 17.7 (86) .0086 12.3 (13) 17.0 (18) .3311 13.3 (13) 12.2 (12) .8305
Pneumonia 6.7 (11) 9.4 (46) .2747 9.4 (10) 6.6 (7) .4481 9.2 (9) 5.1 (5) .2673
Sleep apnea 13.3 (22) 16.8 (82) .2880 17.0 (18) 15.1 (16) .7082 15.3 (15) 12.2 (12) .5341
Syncope 4.8 (8) 5.5 (27) .7319 4.7 (5) 4.7 (5) 1.0000 3.1 (3) 7.1 (7) .1941
Carotid stenosis 0.6 (1) 2.7 (13) .1140 0.9 (1) 2.8 (3) .3127 1.0 (1) 4.1 (4) .1741
Stroke or TIA 8.5 (14) 9.7 (47) .6567 9.4 (10) 9.4 (10) 1.0000 10.2 (10) 12.2 (12) .6509
Liver disease 3.0 (5) 8.6 (42) .0163 4.7 (5) 3.8 (4) .7334 3.1 (3) 4.1 (4) .7003
MELD score 7.5 (6.4-9.1) 8.4 (7.5-10.0) <.0001 7.5 (6.4-9.2) 7.6 (7.5-9.2) .4128 7.5 (6.4-9.2) 7.8 (6.4-9.7) .1738
MELD score>10 13.9 (23) 24.9 (121) .0035 15.1 (16) 11.3 (12) .4171 15.3 (15) 20.4 (20) .3511
Last hematocrit 40.2 (37.0-43.0) 38.0 (34.0-41.1) <.0001 39.0 (36.2-42.6) 39.2 (37.0-42.2) .9366 38.7 (36.0-42.0) 39.5 (36.6-43.0) .4116
Mediastinal radiotherapy 0.6 (1) 3.9 (19) .0339 0.9 (1) 0.9 (1) 1.0000 1.0 (1) 3.1 (3) .3123
Albumin 3.9 (3.6-4.2) 3.7 (3.3-4.0) <.0001 3.7 (3.5-4.1) 3.8 (3.5-4.0) .8327 3.7 (3.5-4.0) 3.8 (3.5-4.1) .2636
Previous CABG 1.8 (3) 6.4 (31) .0239 2.8 (3) 3.8 (4) .7007 2.0 (2) 3.1 (3) .6505
Previous valve 3.7 (6) 7.8 (38) .0675 5.7 (6) 6.6 (7) .7747 6.1 (6) 8.2 (8) .5791
Preoperative cardiac status
Previous MI 17.6 (29) 33.5 (163) .0001 24.5 (26) 31.1 (33) .2834 24.5 (24) 25.5 (25) .8690
Angina class .0046 .9367 .8426
CCS I 1.2 (2) 0.6 (3) 0.9 (1) 0.9 (1) 1.0 (1) 1.0 (1)
CCS II 9.1 (15) 11.9 (58) 11.3 (12) 10.4 (11) 13.3 (13) 11.2 (11)
CCS III 13.3 (22) 17.0 (83) 18.9 (20) 15.1 (16) 17.3 (17) 12.2 (12)
CCS IV 7.3 (12) 16.6 (81) 11.3 (12) 10.4 (11) 11.2 (11) 13.3 (13)
No symptoms 69.1 (114) 53.8 (262) 57.5 (61) 63.2 (67) 57.1 (56) 62.2 (61)
Cardiac presentation at
admission
<.0001 .7212 .6259
No symptoms 49.1 (81) 29.8 (145) 34.0 (36) 31.1 (33) 36.7 (36) 38.8 (38)
NSTEMI 4.2 (7) 10.9 (53) 6.6 (7) 4.7 (5) 6.1 (6) 11.2 (11)
STEMI 4.2 (7) 2.9 (14) 6.6 (7) 2.8 (3) 7.1 (7) 3.1 (3)
Stable angina 4.8 (8) 8.8 (43) 6.6 (7) 6.6 (7) 7.1 (7) 5.1 (5)
Ischemia unlikely 22.4 (37) 24.0 (117) 26.4 (28) 30.2 (32) 22.4 (22) 22.4 (22)
Unstable angina 15.2 (25) 23.6 (115) 19.8 (21) 24.5 (26) 20.4 (20) 19.4 (19)
Proximal LAD disease>70 12.1 (20) 19.1 (93) .0408 17.0 (18) 12.3 (13) .3311 17.3 (17) 17.3 (17) 1.0000
Atrial fibrillation/flutter 23.8 (39) 27.3 (133) .3753 22.6 (24) 21.7 (23) .8687 22.4 (22) 24.5 (24) .7361
Preoperative inotropes 1.8 (3) 2.3 (11) .7358 2.8 (3) 2.8 (3) 1.0000 2.0 (2) 1.0 (1) .5607
Preoperative steroids 0.6 (1) 1.4 (7) .4019 0.9 (1) 1.9 (2) .5609 1.0 (1) 3.1 (3) .3123
(Continued)
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TABLE 1. Continued
Characteristic
Full patient population (n ¼ 652) Group 1 (n ¼ 212) Group 2 (n ¼ 196)
Extubated
in OR
(n ¼ 165)
Extubated
12 h
(n ¼ 487) P value
Extubated
in OR
(n ¼ 106)
Extubated
12 h
(n ¼ 106) P value
Extubated
in OR
(n ¼ 98)
Extubated
<6 h
(n ¼ 98) P value
EF (%) 53.3  10.0 51.2  13.3 .0361 52.8  9.9 51.6  14.0 .4734 53.0  9.3 52.1  13.4 .5609
Procedural information
Procedure type <.0001 .1117 .0897
CABG 25.5 (42) 37.8 (184) 35.8 (38) 29.2 (31) 37.8 (37) 30.6 (30)
CABG þ other 0.0 (0) 1.6 (8) 0.0 (0) 0.9 (1) 0.0 (0) 2.0 (2)
CABG þ valve 1.2 (2) 14.8 (72) 1.9 (2) 10.4 (11) 2.0 (2) 6.1 (6)
CABG þ valve þ other 0.6 (1) 4.1 (20) 0.9 (1) 0.0 (0) 1.0 (1) 3.1 (30
Other 9.1 (15) 2.5 (12) 7.5 (8) 3.8 (4) 9.2 (9) 2.0 (2)
Valve 44.8 (74) 23.0 (112) 37.7 (40) 39.6 (42) 35.7 (35) 36.7 (36)
Valve þ other 18.8 (31) 16.2 (79) 16.0 (17) 16.0 (17) 14.3 (14) 19.4 (19)
Status <.0001 .4435 .7543
Elective 80.6 (133) 56.1 (273) 69.8 (74) 74.5 (79) 71.4 (70) 69.4 (68)
Urgent 19.4 (32) 43.9 (214) 30.2 (32) 25.5 (27) 28.6 (28) 30.6 (30)
Operation incidence .0232 .2565 .3317
First cardiac operation 94.5 (156) 86.0 (419) 92.5 (98) 89.6 (95) 91.8 (90) 85.7 (84)
First reoperation 4.2 (7) 12.3 (60) 5.7 (6) 9.4 (10) 6.1 (6) 12.2 (12)
Second reoperation 1.2 (2) 1.2 (6) 1.9 (2) 0.0 (0) 2.0 (2) 2.0 (2)
Third reoperation 0.0 (0) 0.4 (2) 0.0 (0) 0.9 (1) 0 0
Operative approach <.0001 .0754 .0105
Full sternotomy 40.0 (66) 90.6 (441) 61.3 (65) 64.2 (68) 67.3 (66) 66.3 (65)
Partial upper sternotomy 11.5 (19) 5.1 (25) 10.4 (11) 19.8 (21) 7.1 (7) 19.4 (19)
Mini-right thoracotomy 38.8 (64) 2.9 (14) 17.0 (18) 10.4 (11) 15.3 (15) 11.2 (11)
Mini-left thoracotomy 7.3 (12) 0.6 (3) 7.5 (8) 1.9 (2) 7.1 (7) 0.0 (0)
Minimally invasive other 2.4 (4) 0.8 (4) 3.8 (4) 3.8 (4) 3.1 (3) 3.1 (3)
CPB time 131.6 (70.1) 129.5 (61.2) .73 120.5 (69.9) 142.4 (66.2) .02 117.1 (67.0) 134.2 (66.1) .074
Data presented as mean  standard deviation,% (n), or median (interquartile range). BMI, Body mass index; CHF, congestive heart failure; HbA1c, hemoglobin A1c; CVD,
cerebrovascular disease; CVA, cerebrovascular accident; PVD, peripheral vascular disease; TIA, transient ischemic attack; MELD, Model for End-Stage Liver Disease score;
CABG, coronary artery bypass grafting;MI, myocardial infarction; CCS, Canadian Cardiovascular Society; NSTEMI, non–ST-segment elevation myocardial infarction; STEMI,
ST-segment elevation myocardial infarction; LAD, left anterior descending artery; EF, ejection fraction; CPB, cardiopulmonary bypass; OR, operating room.
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Mbecause prolonged mechanical ventilation has been linked
to poor outcomes and mortality.3-5 Early or ‘‘fast-track’’
extubation protocols have been identified as a method
to safely improve outcomes and reduce the postoperative
ICU time without the need for reintubation.6-8,15,16 Early
extubation within<6 or 12 hours has been predominantly
studied after coronary artery bypass grafting (CABG), with
many studies highlighting off-pump techniques.7-9,15-18 In
our quaternary center, the use of off-pump CABG has
been a rare and selective practice. Beginning in mid-2011,
we applied the principles of protocolized early extubation
strategies similar to those of Fitch and colleagues15 to
improve our postoperative extubation times. Observing
that anesthesia technique variability had an affect on extu-
bation, we implemented a standardized anesthetic protocol
for all cardiac surgical procedures. This enabled a compre-
hensive strategy to mitigate prolonged ventilation across all
operation types. OR extubation was initially applied to
those undergoing minimally invasive right thoracotomy
mitral valve repair operations; however, by January 2012,
this experiencewas applied to all nonemergency operations,
regardless of the incision type, procedure complexity, or
redo status. Although the merits of early or ‘‘fast-track’’The Journal of Thoracic and Carextubation are clear, any additional advantage potentially
conferred by OR extubation is unknown. Therefore, our
clinical quality improvement objective was to apply the
principles of preoperative and intraoperative protocolized
care pathways of extubation to all operations and assess
the potential benefits of OR extubation. In our study, the
procedures addressed the breadth of conventional on-
pump cardiac operations, including multivalve surgery,
concomitant open Cox-maze IV procedures, and valve
plus CABG. Nearly 10% of matched patients had had a pre-
operative stroke and a Model for End-Stage Liver Disease
score>10 and had undergone redo operations. One quarter
were in New York Heart Association class III-IV heart fail-
ure and had undergone concomitant open multiprocedure
valve operations. With an average body mass index of
28 kg/m2, our patients approached the obesity definition
of 30 kg/m2, and 15% had sleep apnea.
The practice of OR extubation is not without controversy,
with some detractors evoking a catecholamine stress
response or hypoxia-related injury related to premature
extubation that could result in myocardial compromise
and cardiopulmonary embarrassment.11-13 The argument
has been that the incidence of bleeding and airwaydiovascular Surgery c Volume 148, Number 6 3105
TABLE 2. Postoperative healthcare usage and clinical outcomes for the propensity matched groups by extubation status
Outcome
Group 1 (n ¼ 212) Group 2 (n ¼ 196)
Extubated
in OR
(n ¼ 106)
Extubated
12 h
(n ¼ 106) P value
Extubated
in OR
(n ¼ 98)
Extubated
<6 h
(n ¼ 98) P value
OR time (min)
Total OR time (patient in–patient out) 374 (316-441) 378 (331-428) .32 379 (316-439) 384 (339-432) .21
Surgery completion to patient out 22 (19-30) 20 (15-25) .0035 23 (19-31) 20 (15-25) .0024
LOS
Total ICU (h) 26.0 (22.0-30.0) 30.5 (25.0-51.0) .0004 26.8 (22.0-31.0) 30.0 (25.0-69.0) <.0001
Surgery completion to discharge (d) 5.0 (4.0-6.0) 6.0 (5.0-7.0) .0008 5.0 (4.0-6.0) 6.0 (4.0-7.0) .0005
Cost
ICU (US $) .0005 .0272
Mean  SD 1566  933 2268  1726 1605  1073 2997  6075
Median (IQR) 1298 (1088-1521) 1508 (1236-2510) 1335 (1088-1570) 1484 (1236-3413)
Step down (US $) .0761 .0130
Mean  SD 1898  1013 2208  1705 1881  999 2413  2109
Median (IQR) 1505 (1323-2284) 1870 (1380-2431) 1476 (1309-2222) 1841 (1380-2749)
Surgery completion to discharge (total US $) .0007 .0073
Mean  SD 3464  1430 4477  2694 3486  1442 5410  6843
Median (IQR) 3055 (2575-3964) 3976 (3028-4947) 3025 (2598-3964) 3876 (2998-5456)
Clinical outcome
Reintubation 1.9 (2) 0.0 (0) .50 3.1 (3) 2.0 (2) .6505
Stroke/transient TIA 0.9 (1) 0.9 (1) 1.0 1.0 (1) 0.0 (0) .3161
Reoperation, bleeding 1.9 (2) 0.0 (0) .50 2.0 (2) 0.0 (0) .1552
Pneumonia 0.0 (0) 0.0 (0) — 0.0 (0) 2.0 (2) .1552
Renal failure 0.0 (0) 1.9 (2) .50 0.0 (0) 1.0 (1) .3161
Atrial fibrillation 24.5 (26) 28.3 (30) .62 23.5 (23) 31.6 (31) .2009
Presence of any complication 27.4 (29) 38.7 (41) .096 27.6 (27) 40.8 (40) .0503
Discharged to home 88.7 (94) 72.6 (77) .0009 88.8 (87) 73.5 (72) .0062
30-d mortality 0.0 (0) 0.9 (1) 1.0 0.0 (0) 0.0 (0) —
Data presented as% (n), mean SD, or median (IQR). OR, Operating room; LOS, length of stay; ICU, intensive care unit; SD, standard deviation; IQR, interquartile range; TIA,
transient ischemic attack.
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Mcomplications are high in the immediate postoperative
period and delaying extubation for 6 hours will help to
stabilize those issues before weaning the patient from
ventilatory support. In a nonrandomized study of 100
CABG patients, Montes and colleagues13 noted that
compared with ICU extubation, patients extubated in the
OR had no difference in ICU or hospital LOS but incurred
a reintubation rate of 8% and postoperative myocardial
infarction rate of 3%. The results of that early experience
might be explained by the anesthetic technique used. The
thiopental and pancuronium used in their study are associ-
ated with prolonged recovery. The use of pancuronium
has also been associated with significant residual neuromus-
cular paralysis or recurarization and might play a role in the
greater reintubation rates.20 The use of benzodiazepine-
based techniques has similarly been associated with de-
layed extubation, impaired mental function, and prolonged
ICU time.21 In our center, thiopental and pancuronium have
been replaced by low doses of propofol, etomidate, fenta-
nyl, and shorter acting rocuronium. The practice of high-
dose benzodiazepine cardiac anesthesia has been replaced
by low-dose midazolam restricted to anxiolysis at the onset3106 The Journal of Thoracic and Cardiovascular Surof anesthesia, avoiding repeat ‘‘top-up’’ doses, even during
rewarming on cardiopulmonary bypass. Inhalation anes-
thesia is used and titrated to keep the bispectral index at
40 to 60 to maintain the anesthesia depth without compro-
mising prompt recovery. In our study, we found that not
only was OR extubation safe in terms of no difference in
the low reintubation rates compared with ICU extubation,
but also OR extubation was associated with significant im-
provements in patient mobilization, pulmonary toilet, and a
return to physiologic baseline as manifested by the shorter
ICU times and reductions in LOS, without the sequelae of
an increased incidence of complications.
Earlier experiences with immediate OR extubation were
enhanced by the use of high thoracic epidural anesthesia
and focused on isolated CABG or isolated aortic valve
replacement.16,18,19 Although we used a single intrathecal
(spinal) opioid injection for postoperative analgesia in
only a few of the minimally invasive thoracotomy
operations in the present series (18.4% [39 of 212] in
group 1, 16.8% [33 of 196] in group 2), no patient
received epidural anesthesia. Most patients examined in
our study underwent a sternotomy operation performedgery c December 2014
FIGURE 2. A comparison of clinical and length of stay outcomes between the group 1 matched set of patients who were extubated in the operating room
(n¼ 106) and patients who were extubated outside the operating room12 hours (n¼ 106). A, The percentage of patients Left, who had any complication
and Right, who were discharged from the hospital directly to their home. P values were determined from chi-square statistics from conditional logistic
regression models stratified by the matched pairs. B, The median (red circle) and interquartile ranges (black lines) for the length of stay Left, in the intensive
care unit and Right, from surgery to hospital discharge. P values were based on Wilcoxon signed rank tests stratified by the matched pairs.
Badhwar et al Perioperative Managementon-pump and received conventionally balanced anesthesia.
Although the present study was propensity matched to
include the procedure and incision type, a separate subset
analysis excluding minimally invasive operations further
confirmed the identical outcome reductions associated
with OR extubation.
Resource Usage
The pursuit of high-quality and cost-efficient care is the
touchstone for all cardiac surgical programs in the current
era of value-based healthcare. By understanding the
variability of common cardiac operations, an opportunity
exists for improvement in both quality and resource us-
age.22,23 The complications that occur after our operative
procedures can be among the most costly, not only to our
patients, but also to our healthcare system.24 Methods to
mitigate complications and reduce the LOS after common
cardiac operations serve to provide value and quality divi-
dends. Streamlining the process and procedures to decrease
the extubation time after cardiac surgery is one such
initiative.
Early or ‘‘fast-track’’ cardiac anesthesia protocols have
shownpromising cost effectivenesswith selected operations.TABLE 3. Postoperative healthcare usage and clinical outcomes for the
invasive surgery
Outcome
Group 1 (n ¼ 198)
Extubated
in OR (n ¼ 99)
Extubated
12 h (n ¼ 9
Total ICU stay (h)
Median 26.0 29
IQR 22.0-31.0 25.0-50.0
Surgery completion to discharge (d)
Median 5.0 6.0
IQR 4.0-6.0 5.0-7.0
OR, Operating room; ICU, intensive care unit; IQR, interquartile range.
The Journal of Thoracic and CarIn a randomized controlled trial of isolated CABG
patients, Cheng and colleagues25 showed that substantial
cost savings could be realized when patients were extubated
within 6 hours, helping to set national benchmarks for
CABG. In a Cochrane review of 25 trials and 4118 patients,
fast track cardiac surgery did not increase patient morbidity
or mortality or reduce overall hospitalization; however,
low-dose narcotic techniques and time-based extubation pro-
tocols within 12 hours were responsible for substantial re-
ductions in the ICU stay.26 Chamchad and colleagues27
usedCABGregistry data to confirm that early or evenORex-
tubation could be performedwith a reintubation rate of<1%
and the hospital stay could be reduced by 0.8 day.
In our study, we sought to determine whether OR extuba-
tion could confer enhanced value compared with estab-
lished early ‘‘fast-track’’ intervals for CABG while
applying this strategy for all forms of open cardiac opera-
tions. Because the data on extubation for 12 to 24 hours
after cardiac surgery appears well established, we focused
our analysis on comparing OR extubation to propensity-
matched patients extubated within either<12 hours or<6
hours. We compared the interval from surgery completion
to OR departure and found that OR extubation could bepropensity matched groups by extubation status—without minimally
Group 2 (n ¼ 184)
9) P value
Extubated
in OR (n ¼ 92)
Extubated
<6 h (n ¼ 92) P value
.0055 .0008
27.0 29.5
22.0-31.5 25.0-70.0
.0035 .0003
5.0 6.0
4.0-6.0 5.0-7.0
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Maccomplished efficiently without clinically or fiscally sig-
nificant delays in OR time (Table 2). OR extubation was
performed safely without an increase in morbidity, mortal-
ity, or reintubation across a variety of complex cardiac op-
erations. Although OR extubation appeared to clearly show
a trend toward a decreased overall complication rate, the
difference did not reach statistical significance. We found
that OR extubation after all forms on nonemergency cardiac
operations provided enhanced value through a 20% postop-
erative cost reduction and improvements in the length of
ICU stay, postoperative hospitalization, and direct-to-
home healthy discharge.
Enhancements in surgical and anesthesia techniques
and protocol-driven postoperative critical care management
are enablers for team-based quality care improvement
in cardiac surgery. Extubation in the OR should no longer
be considered unacceptable after low-risk or, even,
moderate-risk cardiac surgery. Extubation of awakened pa-
tients in the OR can offer several advantages, such as avoid-
ance of the excessive sympathetic discharge associated with
endotracheal stimulation, better recovery of vascular tone,
and, potentially, less need for catecholamine support and
improvements in physiologic venous return and related
end-organ perfusion through nonmechanical spontaneous
respiration. Reducing the need for postoperative sedatives
and narcotics can also enhance the normal return to gastro-
intestinal and pulmonary function, thus, minimizing the risk
of related complications. Enhancing the clinical coopera-
tion and communication among the anesthesia, cardiac sur-
gery, and critical care personnel through extubation
protocols is one method of achieving lasting outcome
improvement and value in cardiac surgery.
Study Limitations
The present study was observational and retrospective
and variables other than what were included in the analysis
could have been present and could have affected the results.
Although propensity matching was done to avoid the poten-
tial for selection bias in our study, this method of statistical
adjustment cannot account for unobserved variables that
could have influenced the decision and timing to extubate
a patient in the OR. Although the anesthesia technique
was protocolized, individual anesthesiologists adjusted the
type and dose of the drugs and the timing of their adminis-
tration according to their clinical judgment. This might
have influenced some of the differences in the patient recov-
ery profiles. The effect of OR extubation on the dose
changes of inotropic, vasopressor, and pain medications
was not evaluated in the present study. Our study was not
adequately powered to detect the difference in complica-
tions considering the low event rates for outcomes, such
as myocardial infarction, renal failure, stroke, and 30-day
mortality. Geographical distance and family support was
not recorded; thus, any influence these might have had on3108 The Journal of Thoracic and Cardiovascular Surdirect to home discharge is not known. The present study
of a well-matched limited patient volume cannot replace
the inherent value of a prospective randomized controlled
clinical trial.
CONCLUSIONS
The present study has provided evidence for the safety
and efficacy of OR extubation after adult cardiac opera-
tions. Programmatic transitioning from early postoperative
extubation to immediate OR extubation in low- and
moderate-risk cardiac surgical patients could provide
cost-effective outcome improvement.
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DrGlennWhitman (Baltimore, Md).Dr Badhwar, as you and I
have already spoken this past week, I think this is a tremendous
study and extremely provocative. First, I have a comment. The pro-
pensity analysis was exhaustive, but it is hard to imagine that a
group that is extubated in the OR can be compared with a group
that required 12 hours to be extubated, and only possibly to a group
that required<6 hours. It is hard to imagine why the ICU required
12 hours to extubate a group matched to the intraoperative extuba-
tion group, unless the groups were different.
The second point I wanted to make was that despite the propen-
sity analysis that I had the opportunity to read—and it really was
exhaustive; my congratulations. I think it would be comforting
to see the Society of Thoracic Surgeons risk profile for the patients
in the compared groups, to determine whether those data were
comparable.
Finally, the data you presented does not show closure time to
out-of-room time, which arguably could be significantly longer
in the group extubated intraoperatively. All of us recognize that
as the most expensive time in the entire hospitalization of a patient.The Journal of Thoracic and Car
PYour report is extremely provocative, and if in fact patient
satisfaction significantly benefits by intraoperative extubation,
it might be worth it just for that.
Dr Badhwar. Thank you for your kind comments and for your
leadership and contributions in this field.
The grouping of<12hours and<6 hourswas done predominantly
to answer questions in the published data on the definition of ‘‘fast
tracking.’’ Of the subgroup of 487 patients who were not extubated
in the OR, 356 of those actually required<6 hours. So really this
was a parallel examination of all extubation occurring within
<12 hours but focused to<6 hours, as you very appropriately noted.
In terms of the propensity matching, it indeed incorporated
every risk factor in our adult cardiac database without exclusion.
One of our study limitations, as you point out, pertains to the
OR decision-making regarding the clinical decision to extubate,
which was fully outlined in the report.
We have done an analysis on the OR time expended to extubate.
We examined the anesthesia record for times from ‘‘drapes off’’ to
‘‘wheels out’’ to define time spent from surgery end time to exiting
the room. For patients in the<6-hour ICU extubation group, the
median time was 20 minutes. For the OR extubation group, the
median time was 23 minutes. Therefore, we importantly found
that OR extubation could be performed with a fiscally negligible
difference in OR time.
Thank you for your questions, and I agree with your comments
on patient satisfaction, because this has been a substantial
improvement.
Dr Daniel L. Miller (Marietta, Ga). I enjoyed the presentation.
How has your education of the patient preoperatively changed,
because I think that is a very important part of all this, especially
in getting patients out earlier and what they should expect in that
first 6 to 12 hours. I would appreciate your expansion on that.
Dr Badhwar. Thank you, Dr Miller. The patients were extraor-
dinarily satisfied, obviously, just as were their family and referring
physicians. This has now become our routine for all patients under-
going all cardiac surgery. Starting first in the very early experience
at the end of 2011 with minimally invasive surgery, now every sin-
gle heart operation, regardless of the complexity or redo status, is
prepared for OR extubation. The confidence rate for patients un-
dergoing extubation in the ORwe can somewhat predict from their
clinical findings.We inform all patients to be prepared, to listen for
the nurse’s voice, to listen to the anesthesiologist’s voice, to take
deep breaths instead of small rapid breaths, and it has really
enhanced our patient’s experience with successful OR extubation.
Thank you for your question.diovascular Surgery c Volume 148, Number 6 3109
APPENDIX TABLE E1. Propensity score logistic regression models
Covariate
Propensity for extubation in OR
compared with extubation 12 h (n ¼ 652)
Propensity for extubation in OR
compared with extubation<6 h (n ¼ 521)
Regression
coefficient
estimate
Regression
coefficient
standard error P value
Regression
coefficient
estimate
Regression
coefficient
standard error P value
Age per year 0.0206 0.00979 .0351 0.0247 0.0103 .0169
BMI per 1 U increase 0.0699 0.0220 .0015 0.0562 0.0228 .0136
Current cigarette smoking (yes vs no) 0.9873 0.3399 .0037 0.8234 0.3479 .0179
Noncigarette tobacco use (yes vs no) 1.3032 0.5677 .0217 0.8466 0.5706 .1369
CHF (yes vs no) 0.8614 0.2895 .0029 0.9113 0.2867 .0015
PVD (yes vs no) 0.7869 0.3461 .0230 0.7923 0.3483 .0229
Family history of CAD (yes vs no) 0.5610 0.3087 .0692 0.5025 0.3149 .1106
Chronic lung disease (yes vs no) 0.5276 0.3063 .0850 0.6823 0.3116 .0286
Liver disease (yes vs no) 1.5560 0.6693 .0201 1.9552 1.1717 .0952
Previous heart failure (yes vs no) 0.5977 0.3763 .1122 0.6823 0.3116 .0286
Mediastinal radiotherapy (yes vs no) 1.6128 1.2048 .1807 1.9552 1.1717 .0952
Stroke/TIA (yes vs no) 0.8971 0.4153 .0308 0.9124 0.4292 .0335
Last hematocrit per 1 U increase 0.0531 0.0235 .0241 0.0419 0.0245 .0871
Platelets per 1 U increase 3.6e-6 2.198e-6 .0983 3.25e-6 2.239e-6 .1472
MELD score per 1 U increase 0.0999 0.0446 .0250 0.1393 0.0470 .0031
Total albumin per 1 U increase — — — 0.3156 0.2012 .1167
STEMI/NSTEMI/unstable angina presentation
(yes vs no)
1.4184 0.4328 .0010 0.7653 0.3162 .0155
Full sternotomy (yes vs no) 2.5372 0.2922 <.0001 2.6042 0.2958 <.0001
Urgent procedure (vs elective) 0.7246 0.3116 .0201 — — —
OR, Operating room; BMI, body mass index; CHF, congestive heart failure; PVD, peripheral vascular disease; CAD, coronary artery disease; TIA, transient ischemic attack;
MELD, Model for End-Stage Liver Disease score; NSTEMI, non–ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction.
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